Genetic and pharmacological ablation of STING blunted inflammation and provided partial protection against AKI, suggesting that other mechanisms may trigger inflammatory pathways, including TLR9 activation by mtDNA [304]. The gene discussed is STING1; the disease is acute kidney injury.